Diagnosis of idiopathic myositis: Value of 99mtechnetium pyrophosphate muscle scintigraphy and magnetic resonance imaging in targeted muscle biopsy

Rheumatology International

Volumn 17, Issue 5, 1998, Pages 207-213

  Von Kempis, J ^a   Kalden, P ^a   Gutfleisch, J ^a   Grimbacher, B ^a   Krause, T ^b   Uhl, M ^b   Ketelsen, U P ^b   Volk, B ^b   Rother E ^a   Vaith, P ^a   Peter, H H ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Albert Ludwig University ^*

Author keywords

99mtechnetium pyrophosphate scintigraphy; Biopsy; Diagnosis; Magnetic resonance imaging; Myositis

Indexed keywords

CORTICOSTEROID; CREATINE KINASE; PYROPHOSPHATE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ENZYME BLOOD LEVEL; FEMALE; HISTOPATHOLOGY; HUMAN; IDIOPATHIC DISEASE; INFLAMMATION; ISOTOPE TRACING; MALE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE NECROSIS; MYOSITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT; PRIORITY JOURNAL; RELIABILITY; SCINTIGRAPHY; SEROLOGY; SYMPTOM;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; BIOPSY; C-REACTIVE PROTEIN; CREATINE KINASE; FEMALE; GLYCINE-TRNA LIGASE; HISTIDINE-TRNA LIGASE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOSITIS; TECHNETIUM TC 99M PYROPHOSPHATE;

EID: 6844255228     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002960050036     Document Type: Article

References (36)

1. Miller FW (1994) Classification and prognosis of inflammatory muscle disease. Rheum Dis Clin North Am 20: 811-826
2. Plotz PH, Dalakas M, Left RL, Love LA, Miller FW, Cronin ME (1989) Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med 111: 143-157
3. Plotz PH, Rider LG, Targoff IN, Raben N, O'Hanlon TP, Miller FW (1995) NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 122: 715-724
4. Dalakas MC (1991) Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325: 1487-1498
5. Pachman LM, Maryjowski MC (1984) Juvenile dermatomyositis and polymyositis. Clin Rheum Dis 10: 95-115
6. Pachman LM (1994) Inflammatory myopathy in children. Rheum Dis Clin North Am 20: 919-942
7. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, et al (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 70: 360-374
8. Sigurgeirsson B, Lindelof B, Edhag O, Allander E (1992) Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326: 363-367
9. Callen JP (1994) Myositis and malignancy. Curr Opn Rheumtol 6: 590-594
10. Sayers ME, Chou SM, Calabrese LH (1992) Inclusion body myositis: analysis of 32 cases. J Rheumatol 19: 1385-1389
11. Calabrese LH, Chou SM (1994) Inclusion body myositis. Rheum Dis Clin North Am 20: 955-972
12. Noel E, Tebib J, Walch G, Vauzelle JL, Bouvier M (1991) Focal myositis: a pseudotumoral form of polymyositis. Clin Rheumatol 10: 333-338
13. Barnes Q, Mawr B (1976) Dermatomyositis and malignancy: A review of the literature. Ann Int Med 84: 68-76
14. Casteels I, De Bleecker C, Demaerel P, Van Wilderode W, Missotten L, Wilms G, et al (1991) Orbital myositis following an upper respiratory tract infection: contribution of high resolution CT and MRI. J Belge Radiol 74: 45-47
15. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292: 344-347
16. Tanimoto K, Nakano K, Kano S, Mori S, Ueki H, Nishitani H, et al (1995) Classification criteria for polymyositis and dermatomyositis. J Rheumatol 22: 668-674
17. 99mtechnetium pyrophosphate in patients with neuromuscular disorder. A quantitative study. J Neurol Sci 53: 1-7
18. Yonker RA, Webster EM, Edwards NL, Katz P, Longley S, Petterssen H, et al (1987) Technetium pyrophosphate muscle scans in inflammatory muscle disease. Br J Rheumatol 26: 267-269
19. Reimers CD, Schedel H, Fleckenstein JL, Nagele M, Witt TN, Pongratz DE, et al (1994) Magnetic resonance imaging of skeletal muscles in idiopathic inflammatory myopathies of adults. J Neurol 241: 306-314
20. Fraser DD, Frank JA, Dalakas M, Miller FW, Hicks JE, Plotz P (1991) Magnetic resonance imaging in the idiopathic inflammatory myopathies. J Rheumatol 18: 1693-1700
21. Dubowitz V, Brooke MH (1973) Muscle biopsy: A modern approach. In: Dubowitz V, Brooke MH (eds) Saunders, London
22. Engel AG (1986) Myology: basic and clinical. In: Engel AG Banker BQ (eds) The muscle biopsy. McGraw-Hill, New York, pp 833-843
23. Haddad MG, West RL, Treadwell EL, Fraser DD (1994) Diagnosis of inflammatory myopathy by percutaneous needle biopsy with demonstration of the focal nature of myositis. Am J Clin Pathol 101: 661-664
24. Buchpiguel CA, Roizenblatt S, Lucena-Fernandes MF, Soares JJ, Meneguetti JC, Hironaka FH, et al (1991) Radioisotopic assessment of peripheral and cardiac muscle involvement and dysfunction in polymyositis/dermatomyositis. J Rheumatol 18: 1359-1363
25. 99mdiphosphonate in acutely injured muscle. Relationship to muscle calcium deposition. Neurology 27: 230-238
26. 99mtechnetium diphosphonate into degenerating and regenerating muscle. A correlative histological and biochemical study. J Neurol Sci 51: 339-354
27. Buchpiguel C, Roizenblatt S, Pastor E, Hironka F, Cossermelli W (1996) Cardiac and skeletal muscle scintigraphy in dermatomyositis and polymyositis; clinical implications. Eur J Nucl Med 23: 199-203
28. Fujino H, Kobayashi T, Goto I, Onitsuka H (1991) Magnetic resonance imaging of the muscles in patients with polymyositis and dermatomyositis. Muscle Nerve 14: 716-720
29. Kaufman LD, Gruber BL, Gerstman DP, Kaell AT (1987) Preliminary observations on the role of magnetic resonance imaging for polymyositis and dermatomyositis. Ann Rheum Dis 46: 569-572
30. Olsen NJ, Park JH (1995) MRS and NIRS for muscle disease evaluation. Bull Rheum Dis 44: 4-7
31. Park JH, Olsen NJ, King L Jr, Vital T, Buse R, Kari S, et al (1995) Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis. Arthritis Rheum 38: 68-77
32. Kalovidouris AE (1994) Mechanisms of inflammation and histopathology in inflammatory myopathy. Rheum Dis Clin North Am 20: 881-897
33. Banker BQ, Engel AG (1994) Myology: basic and clinical. In: Engel AG, Franzini-Armstrong C (eds) The polymyositis and dermatomyositis syndromes. McGraw-Hill, New York, pp 1335-1383
34. Devere R, Bradley WG (1975) Polymyositis: its presentation, morbidity and mortality. Brain 98: 637-666
35. Munsat T, Cancilla P (1974) Polymyositis without inflammation. Bull Los Angeles Neurol Soc 39: 113-120
36. Rowland LP, Clark C, Olarte M (1977) Therapy for dermatomyositis and polymyositis. Adv Neurol 17: 63-97